Discovery and Imaging Services | Charles River

discovery & imaging services 

We understand that early discovery is a critical stage in your drug development program. The ability to rule out unsuitable drug candidates early in the process is key to the successful development of a new therapeutic. Working in close collaboration with you, Charles River Discovery and Imaging Services offers streamlined discovery capabilities to meet the rapid timelines and diverse needs required for the most efficient target validation and drug candidate ranking and selection process. With multiple facilities and expert staff in North America, Europe and Asia, we help close the gap between the output of combinatorial chemistry and high-throughput screening and the safety testing required prior to initiation of clinical studies.

 

We are pleased to welcome MIR Preclinical ServicesPiedmont Research Center and Cerebricon to the Charles River family as part of our expanding portfolio of world-class Discovery and Imaging Services. With these acquisitions, our discovery expertise has further expanded in key therapeutic areas including CNS, inflammation and oncology, with service offerings that are now complemented by cutting-edge in vivo imaging capabilities.

Whether you need a single study or intend to outsource your entire discovery program, our capacity and range of services can help move your product from animal to man in a rational, cost-effective, and timely manner.


To supplement your discovery programs, we offer a full range of basic research services, including Disease Models, Surgical Services and Expression Testing. Once your drug has passed the discovery milestone, we provide a seamless transition to Preclinical Development and Clinical Trials, creating a more efficient program that can save you valuable time and accelerate your drug development, exactly.
Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 09 - New Endotoxin Data Management Soft...
Mar 08 - Rodent Intravenous Infusion Capabi...
Apr 07-Apr 10 - La Grande Motte, France - Perspectives in Percutaneous Penetration: 12t...
Mar 22-Mar 23 - San Francisco, CA - 2010 PMF Bacterial Endotoxin Summit
May 05-May 05 - Tempe, AZ - Rodent Colony and Disease Management Considerations – A Sem...
view all
Veterinary Pathologist II Reno, NV
Corporate Sr. VP, Corporate Development 

Charles River Laboratories, Inc.